Australian PrEP trial leads to unprecedented reductions in HIV transmission
Recent HIV infections in gay and bisexual men in New South Wales have declined by almost one-third following the trial of an HIV prevention medication called PrEP (Pre-Exposure Prophylaxis), according to Kirby Institute research published in The Lancet HIV on October 18.
These globally unprecedented reductions provide strong evidence to support the large-scale, targeted provision of PrEP to prevent HIV transmission.
The new research, funded by NSW Health, reports the findings from the NSW PrEP trial (called EPICNSW), which was launched in March 2016.
When taken daily, PrEP prevents HIV negative people from acquiring the virus.
Offsite Linkby Anonymous | reply 2 | November 23, 2018 3:41 AM
|
Why all of a sudden, the twinks are going for bareback. I'm an old duffer (been out 45 yrs) and when I was in my prime it was always with the bottom on his back, legs raised! Looking into the eyes off your 'trick', lover or whatever was more sexual arousing with passionate kisses from the neck (hickey) down tongue lapping all over his body, then finding the family jewels, then to the object of your affection! Do you think it is more masculine to be poked from the rear? (Just ask'en)
by Anonymous | reply 1 | November 23, 2018 3:29 AM
|
[quote]an HIV prevention medication called PrEP
PrEP isn't the name of the medication. The medications are tenofovir and emtricitabine, which are commonly used in a variety of HIV drugs, and in this combination are sold under the brand name Truvada. PrEP is short for Pre-Exposure Prophylaxis.
by Anonymous | reply 2 | November 23, 2018 3:41 AM
|